Eculizumab as a treatment for atypical hemolytic uremic syndrome secondary to carfilzomib Candela Moliz, Eduardo Gutiérrez, Teresa Cavero, Beatriz Redondo, Manuel Praga

Hepatotoxicity associated with eculizumab in a patient with atypical hemolytic uremic syndrome Aysegul Oruc, Yavuz Ayar, Berna Aytac Vuruskan, Abdulmecit Yildiz, Nimet Aktas, Mahmut Yavuz, Mustafa Gullulu, Kamil Dilek, Alparslan Ersoy

Late onset of de novo atypical hemolytic–uremic syndrome presented on a simultaneous pancreas and kidney transplant recipient successfully treated with eculizumab Francisco Javier Juega-Mariño, Neus Sala, Dolores López, Laura Cañas, Josep Bonet, Ricardo Lauzurica